Sphingosine 1-phosphate S1P<sub>2</sub> and S1P<sub>3</sub> receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury
Christopher K. Means(University of California, San Diego), Joan Heller Brown(Lancaster General Hospital), Jerold Chun(Sanford Burnham Prebys Medical Discovery Institute), Zhuangjie Li(University of California San Diego), Tong Zhang(South China Agricultural University), Isao Ishii(Showa Pharmaceutical University), Chun-Yang Xiao(Harvard University Press), Jeffrey H. Omens(University of California San Diego)
American Journal of Physiology-Heart and Circulatory Physiology
February 10, 2007
Cited by 217
Related Papers
Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain
|Nature Biotechnology|2017|1.1k
Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain
|Science|2016|1.1k
LPA Receptors: Subtypes and Biological Actions
|The Annual Review of Pharmacology and Toxicology|2010|851
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
|Nature Medicine|2007|820
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
|Clinical Neuropharmacology|2010|794